Albcura is founded in 2017, as a research-based manufacturing company aiming to solve unattended industrial problem with our expert team. We focus on GMP quality Animal Origin Free recombinant proteins for bioprocess, pharmaceutical excipient, and clinical cell culture applications. In 2018, we filed patents of our formulation technology and launched our deAlbumin® product line, and we will continue to bring more innovative products to serve our customers. Visit https://www.albcura.com/ for more information.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.